Top 10 Most-Watched Unlisted Shares in 2026: What's Driving HNI Interest
Reviewed by Kanishk Dev Bangia, NISM Series XV Certified Research Analyst
Last Updated: May 2026 | Reg. No: NISM-202300182946
HNIs and retail investors allocated nearly ₹716 crores to pre-IPO placements of nine firms in 2025, a staggering increase from ₹387 crores invested in 2024. Secondary exchanges including UnlistedZone, Planify, Stockify, and Altius Investech have recorded their busiest year ever. The Indian unlisted stock market of 2026 is not just a secondary platform for trading; it has become the venue where India's top private firms are traded openly, sometimes well before their IPOs.
This guide details the ten most active unlisted stocks in terms of HNI & retail investor interest in 2026, their business profile, reasons behind their popularity, and inherent risk factors involved. This is information. Not advice. The intent here is only to provide knowledge, not investment direction.
TL;DR
1. NSE (National Stock Exchange)
NSE Unlisted, trading at about ₹1,992 in May 2026, with a 52-week range of ₹1,678-2,470, is the largest player in the Indian unlisted market. NSE controls an almost monopoly position in the market for equity derivatives and cash market volumes. Long-term investors have enjoyed more than 10x returns over the past 7-8 years.
Why it is attractive: NSE has filed documentation and obtained necessary approvals for its IPO over the period of 2025-2026. Market valuations have touched ₹5 lakh crore in the unlisted market. The IPO trigger remains the sole catalyst for continued investment by HNIs.
Risk involved: Regulatory time frame. The SEBI's process of approval for the NSE IPO filing has changed multiple times. Investors who bought stocks at higher prices above ₹2,400 due to expectations of imminent listing have witnessed sideways movement.
2. Tata Capital
Financial Services arm of the Tata Group – including consumer lending, corporate lending and wealth management. Tata Capital declared its plans for an IPO and ranks among the top of conviction pre-IPOs based on the AUM metric.
What’s fueling demand: Tata brand, scale and relative lower-risk IPO story (with robust cash flows and compliance stance).
Risks involved: Potential tightening of regulations in the NBFC segment from the RBI. Exposure to the lending business to the interest cycle and asset quality risks. IPO valuation highly dependent on credit cycle at the time of filing.
3. OYO (Oravel Stays)
OYO's DRHP journey in India had the most reissues amongst all companies that went IPO – multiple filings followed by multiple rejections. As it stands in 2026, OYO has managed to reorganize their business model of hotel operations and focus more on franchises and premium segment expansion.
What's fueling interest: contrarian bet. Post 2-3 years of negative news flow, OYO has managed to deliver a significantly improved P&L versus their peak bashing period. High net worth individuals, who invested at significantly discounted valuations, are waiting for their next filing opportunity.
The key risk here is premium discounting. The company's track record of value erosion and IPO delay has conditioned the market to discount any projections made by the management.
4. Reliance Retail
India's leading organized retailer by revenue in terms of the consumer retail unit of Reliance Industries. Reliance Retail's unlisted stock trades on secondary markets despite the firm staying private.
Why it matters: Reliance is said to be readying an IPO of its Reliance Retail business as a standalone unit, which would be among India's biggest IPOs by size of issue. Unlisted shareholders have held stakes for many years in a leading company.
Main risk: Time will depend on the strategic decision made by Reliance Industries, which is unpredictable for any outsider investor. An expected IPO for several years now does not have a clear timeline set. Investment capital can remain locked beyond usual IPO periods.
5. Chennai Super Kings (CSK)
Only Indian sports team franchise with active trading of unlisted shares on secondary markets. CSK Cricket Ltd owns the IPL rights for Chennai Super Kings franchise team.
Reasons behind its attractiveness: novelty + IPL economics. The valuation of the IPL rights has grown exponentially over several cycles of media rights. The CSK shares appeal to retail investors seeking exposure to the IPL economics without acquiring the BCCI or a broadcaster.
Important risk factor: no IPO plans announced. No IPO dates have been indicated by CSK. This is effectively a closed-ended investment — you invest in the franchise economics rather than an exit. Liquidity lower compared to other companies on this list.
6. Hero FinCorp
Hero Group’s NBFC unit for funding purchases of two-wheelers, MSME loans, and personal finance needs. Hero FinCorp has already filed their DRHP and has one of the more credible IPOs listed.
Drivers: Clean Hero brand name, strong captive client base (two-wheeler purchasers), and a more credible timeline for the IPO.
Main risk: Quality of assets at NBFC. Several of the largest shareholder value declines in the private equity segment in 2024-2025 have been due to NBFC companies where credit costs were higher than expected.
7. BOAT (Imagine Marketing)
Largest consumer audio brand in India in terms of volumes — wireless earbuds, headphones, and smartwatches. Imagine Marketing, the parent company, withdrew its previous DRHP and is now gearing up for another one.
What’s fuelling investor interest: brand recognition among consumers + growing wearable/audio segment in India. Margins under pressure due to competition is a well-known factor.
Risks involved: brand margins decline with scale since the marketing costs have to increase. Previous DRHP showed growth in revenues but deteriorating unit economics.
8. PharmEasy / API Holdings
Online Pharmacy + Healthcare Aggregator. PharmEasy was earlier valued at around $5.6 billion. Later down rounds and restructuring reduced the valuation substantially. The company is now dealing with deleveraging issues and operational discipline.
Motivation: Deep Value Play. HNIs who joined at a valuation post-down round have optionality on continued adoption and future success for the healthcare play as well as potential IPO at a recovered multiple.
Risk factor: Down round history forms a permanent part of discussions regarding capital structure. IPO will always price based on the last private market valuation, which might even be below the peak.
9. Studds Accessories
Largest helmet producer in India. Studds has been working quietly on its listing plan for many years now. The two-wheeler safety regulation has resulted in stable demand.
The reasons behind interest: stable demand + healthy balance sheet compared to other consumer discretionary companies. IPO has faced repeated delays but its fundamentals haven’t budged.
The main concern: timing issue. Investor interest has been building for 3+ years now saying “almost ready to list.” Liquidity remains an issue until the filing actually happens.
10. Polymatech Electronics
Semiconductor packaging and electronics fabrication. Polymatech sees advantage in India's PLI-scheme push on electronics manufacturing. The stock has been gaining prominence amid the "Indian semiconductor narrative" getting the policy support wind behind its back.
Why there's buzz: India's semiconductor manufacturing narrative. Capital and policy focus is going into this particular niche.
Main risk: execution. India's semiconductor manufacturing narrative is still a relatively new narrative with little track record. Polymatech peer comparison is not as straightforward as consumer/financial stocks.
How These Shares Are Priced + Where to Track
Unlisted stocks do not have an exchange price. Their “market price” is based on what the secondary platform market decides to negotiate. Different secondary markets give different prices for the same stock at any given point in time; there could be a 3% to 8% variation.
Some sources that monitor the prices are UnlistedZone, Planify, Stockify, Altius Investech, and InCred Money. All of them update their prices every few days. Volumes are low because even the most popular stock (NSE) trades less than a thousand units in a week.
The 5 Risks Common to All 10 Names
- Risk of liquidity. The secondary market could become illiquid for weeks. The spread between the buy price and sell price increases. You will not be able to exit your investment when you would like to.
- Timing of IPO. All companies in this list have had their planned dates for going public pushed forward at some point. Capital planning should factor in 24–36 months.
- Lock-in period commences with filing of DRHP. With the filing of DRHP, the 6-month lock-in period begins. Refer to the SEBI lock-in period guidelines for further details.
- Taxes – LTCG after 24 months. In order to qualify for long-term capital gains (at 12.5% without indexation), you need to hold the stock for 24 months, not 12 months.
- Information gap. Pre-IPO firms provide less information than their listed counterparts. You may have to rely solely on the research provided by platforms or analysts.
Frequently Asked Questions
Q : What is the lowest amount to buy shares that aren’t listed in an exchange?
Each exchange has their own lowest amount ranging from ₹50,000 to ₹2,00,000 based on lot sizes and the underlying company. The minimum amount in the case of NSE Unlisted is usually more compared to other smaller companies.
Q : Is the price fair enough to buy these shares?
Comparing the prices in at least two exchanges like UnlistedZone, Planify, Stockify and Altius Investech would help you identify whether the price you are looking at is reasonable. An 8-3% difference between platforms is acceptable; however, any greater variation implies that pricing is out of date in that platform.
Q : Are unlisted shares a safe bet?
They entail greater risks compared to listed shares: lack of transparency, illiquidity, longer investment horizon, and risk related to the IPO execution of the company. Unlisted shares suit individuals who have a timeframe of 24–36 months to invest, have well-diversified portfolio, and the ability to lock money into the investment.
Q : And what if my company decides not to go public?
You still keep them. Some firms provide periodic opportunities to sell back the shares; others get acquisition and you receive cash based on the terms; still some do not go public at all. Liquidity through secondary market is still available for popular stocks even without IPO event.
Q: Can unlisted shares be transferred to my family?
Yes, usually using off-market demat transfer, provided that the articles of association of the company and the right-of-first-refusal clause, if present, do not preclude such action. Transfers as gifts among immediate family members are usually tax-free under Section 56 of the Income-tax Act.
Q: When will the NSE IPO really happen?
As of May 2026, no official date has been mentioned. However, the process associated with the filing of DRHP has continued throughout 2025-2026, and the company has passed several hurdles. Timing is subject to SEBI clearances and market dynamics. It is advisable to allocate the necessary capital 12-24 months after this article's publication.
Q : Which of these 10 is the safest unlisted stock?
There is no “safest”; each comes with its own risk profile. NSE Stock is best positioned on branding and IPO route while it is also most highly valued. Tata Capital is largest and well-capitalized but faces challenges in NBFC space. CSK Stock has nothing to say about IPOs. All stocks need to be considered on the basis of your personal perspective.
Q : Which documents are required to purchase unlisted shares?
The documents you will require include PAN Card, Aadhaar Card, Demat Account Number (NSE or BSE), Bank Account Statement for money transfer and KYC compliance with the platform. The transaction takes place through off market demat instruction where your depository transfers the stock after receiving the same from the depository of seller.
Disclaimer:
This is written for educational and informational purposes only. Nothing here constitutes investment advice or a recommendation to buy or sell securities. All data is sourced from publicly available information. Investments in securities markets are subject to market risks — please read all offer documents carefully before investing.
